Testing effectiveness (Phase 2)Ended earlyNCT00718809
What this trial is testing
Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer
Who this might be right for
Invasive Thymoma and Thymic CarcinomaRecurrent Thymoma and Thymic CarcinomaStage III Thymoma+2 more
National Cancer Institute (NCI) 21